Advertisements

Stocking Stuffers

 

BriaCell Therapeutics Corp. (BCT:CA) Stock Quote

Detailed Quote for BriaCell Therapeutics Corp (BCT:CA)
$ 0.105   -0.01 (-8.70%) Volume: 426k 3:08 PM EDT Mar 22, 2019
Today 5d 1m 3m 1y more
Last Price
0.105
Change $
0.01
Change %
8.70%
Tick
  
Bid
0.105
Bid Size
186,500
Ask
0.11
Ask Size
50,000
Open
0.11
High
0.11
Low
0.105
Prev Close
0.115
Last Trade
3:08
Volume
426k
52 Wk Hi
0.180000007
52 Wk Low
0.07
Market Cap
17.22m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
164,023,874
EPS (TTM)
-0.039999999
PE Ratio
N/A
Exchange
TSXV
News and Media for BriaCell Therapeutics Corp (BCT:CA)
Sector News | Topic News
News for BriaCell Therapeutics Corp (BCT:CA)
Fri, Mar 22, 2019
10:30 AM BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Announces Changes to Board of Directors and a Private Placement Offering - NetworkNewsWire
Thu, Mar 21, 2019
8:30 AM NetworkNewsBreaks - BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Announces $2M Non-Brokered Private Placement Offering - NetworkNewsWire
Wed, Mar 20, 2019
4:05 PM BriaCell Announces $2,000,000 Non-Brokered Private Placement Offering - GlobeNewswire
Mon, Mar 18, 2019
10:45 AM BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Achieves Important Milestones in Fight against Advanced Breast Cancer - NetworkNewsWire
8:30 AM NetworkNewsBreaks - BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Appoints BioPharma Industry Experts to Board of Directors - NetworkNewsWire
6:30 AM BriaCell Welcomes BioPharma Industry Experts to its Board of Directors - GlobeNewswire
Tue, Mar 12, 2019
2:45 PM NetworkNewsBreaks - BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Secures Investment to Back Clinical Research - NetworkNewsWire
Thu, Mar 07, 2019
6:30 AM BriaCell Therapeutics Corp. Highlights Recent Clinical and Scientific Achievements in Exclusive Audio Interview with\u00A0NetworkNewsWire - GlobeNewswire
Mon, Mar 04, 2019
9:45 AM BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Receives Equity Investment to Support Novel Immunotherapy Clinical Research - NetworkNewsWire
Thu, Feb 28, 2019
4:30 PM Innovation in Breast Cancer Treatment: Combination and Off-the-Shelf Personalized Immunotherapies - Investing News Network
Tue, Feb 26, 2019
8:30 AM NetworkNewsBreaks - BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Director to Invest C$500,000 in Private Placement Financing - NetworkNewsWire
6:30 AM BriaCell Announces C$500,000 Equity Investment by BriaCell Director - GlobeNewswire
Fri, Feb 22, 2019
11:00 AM BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) to Announce Breast Cancer Immunotherapy Findings at Key Oncology Conferences - NetworkNewsWire
Tue, Feb 19, 2019
9:45 AM BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Targets Advanced Breast Cancer with Proprietary Immunotherapy - NetworkNewsWire
8:30 AM NetworkNewsBreaks - BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) to Present Clinical and Scientific Findings at Key Oncology Conferences - NetworkNewsWire
6:30 AM BriaCell to Present Clinical and Scientific Findings with New Insights at Key Oncology Conferences - GlobeNewswire
Wed, Feb 13, 2019
3:15 PM NetworkNewsBreaks - Newly Appointed Board of Directors Member Increases Beneficial Ownership of BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) - NetworkNewsWire
Tue, Feb 12, 2019
7:57 PM Jamieson Bondarenko Acquires 11.0% Beneficial Ownership of BriaCell Therapeutics Corp. - GlobeNewswire
8:30 AM NetworkNewsBreaks - BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Appoints New Member to Board of Directors - NetworkNewsWire
6:30 AM BriaCell Appoints Jamieson Bondarenko to its Board of Directors - GlobeNewswire
More News for BCT:CA >>

Tags for BriaCell Therapeutics Corp.

Research stocks or mutual funds related to BriaCell Therapeutics Corp. by keywords or tags. Find companies that have a similar focus to BCT:CA. The keywords below have been associated to BCT:CA by either user submission or electronic means.